CymitQuimica logo

CAS 869572-92-9

:

Tecovirimat

Description:
Tecovirimat, also known by its development code ST-246, is an antiviral medication primarily used for the treatment of orthopoxvirus infections, including smallpox. It functions by inhibiting the viral protein involved in the formation of the viral envelope, thereby preventing the virus from spreading within the host. Tecovirimat is characterized by its selective action against poxviruses, making it a crucial therapeutic option in the event of a smallpox outbreak or bioterrorism threat. The substance is administered orally and has been shown to have a favorable safety profile in clinical studies. Its mechanism of action involves targeting the viral envelope protein, which is essential for the virus's ability to exit infected cells. Tecovirimat is classified as a small molecule drug and has been granted FDA approval for use in specific circumstances, reflecting its importance in public health preparedness. As a synthetic compound, it is distinct from traditional vaccines, providing an alternative treatment strategy for viral infections that pose significant health risks.
Formula:C19H15F3N2O3
InChI:InChI=1/C19H15F3N2O3/c20-19(21,22)9-3-1-8(2-4-9)16(25)23-24-17(26)14-10-5-6-11(13-7-12(10)13)15(14)18(24)27/h1-6,10-15H,7H2,(H,23,25)/t10-,11+,12+,13-,14-,15+
InChI key:InChIKey=CSKDFZIMJXRJGH-VWLPUNTINA-N
SMILES:O=C1[C@]2([C@]([C@@]3([C@@]4([C@]([C@]2(C=C3)[H])(C4)[H])[H])[H])(C(=O)N1NC(=O)C5=CC=C(C(F)(F)F)C=C5)[H])[H]
Synonyms:
  • ST 246
  • Benzamide, N-[(3aR,4R,4aR,5aS,6S,6aS)-3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)-, rel-
  • rel-N-[(3aR,4R,4aR,5aS,6S,6aS)-3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)benzamide
  • Tecovirimat
  • SIGA 246
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.